Study to Evaluate the Safety of FSR Peptide Versus Placebo Following Punch Biopsy
NCT04473859
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Wound Heal
Interventions
DRUG:
FSR Peptide 20μM
DRUG:
FSR Peptide 50μM
DRUG:
FSR Peptide 100μM
DRUG:
FSR Peptide 200μM
DRUG:
Placebo
Sponsor
Xequel Bio, Inc.